Dylan M. Morris

Dr. Dylan Morris serves as Managing Director at Insight Partners. He served as a Board Obsserver at NanoMosaic. He serves as a Board Member at Cirisum Biotechnologies, Profluent Bio, ImmuneBridge, Gameto, DEM BioPharma, Unlearn, ArrePath, Cirsium Biotechnologies, Deciduous Therapeutics, Dyno Therapeutics, Superluminal Medicines, Switch Therapeutics and as a Board Observer at Plexium. Before becoming an investor, he co-founded Integrated Plasmonics, a venture-backed point-of-care diagnostics startup. At Integrated Plasmonics, he was responsible for fundraising, recruiting, business development, and corporate strategy. He previously served as Executive, Investment Team at Innovation Endeavors. He received his bachelor's degree in Computer Science from Harvard University, where he conducted original research in primate cognitive neuroscience. He worked in the software industry for several years before enrolling in a Master's Program at the California Institute of Technology. His research at Caltech involved computational investigations into bacterial structural biology. He received his AB in Computer Science from Harvard University.